R&D Targeting COVID-19 and cancer with immunotherapy advancement... Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform.
Videos Health Innovators – Jo Brewer, Adaptimmune In this episode of Health Innovators, pharmaphorum founder Paul Tunnah interviews Jo Brewer, senior vice president of allogeneic res
Views & Analysis Deep Dive: Oncology 2021 This has probably been the toughest year for oncology researchers in memory.
Views & Analysis Changing focus to cachexia may be key to improved cancer out... Cachexia could be the next blockbuster area in cancer therapeutics because of its link to survival outcomes. Physician and researcher Dr.
Views & Analysis The next generation of immunotherapy? Innate Pharma targets ... Clinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to fight cancer.
Events Partner Content Triple Negative Breast Cancer Drug Development Digital Summi... Fast-track the Discovery & Development of TNBC
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
